Sector Update: Healthcare Shares Flat Pre-Market; Amedisys Posts Bigger-Than-Expected Adjusted Q4 Loss

By Staff,

Shutterstock photo

Top Health-care stocks:

JNJ: flat

PFE: -0.25%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly flat in pre-market trade Wednesday.

In health-care-stocks news, Amedisys ( AMED ) reported an adjusted Q4 loss that was wider than expected while sales fell but exceeded estimates.

The provider of personalized health-care services posted a Q4 net loss of $9.6 million, or $0.30 per share, compared with a prior-year loss of $106.8 million, or $3.52 per share. The year-earlier period was weighed down by goodwill and other impairment charges of $162.1 million.

Specialty pharmaceutical company SciClone Pharmaceuticals ( SCLN ) reported Q4 earnings and revenue below analysts' expectations while forecasting weaker-than-expected 2014 earnings.

Shares tumbled 6% in recent pre-market trading to $4.42, in a 52-week range of $4.25 to $6.30.

The company reported Q4 GAAP earnings of $36,000, or $0.00 per share, compared with the prior-year period's $1.9 million, or $0.03 per share. Non-GAAP EPS was $0.07, compared with $0.04 EPS for the same period in 2012. Analysts polled by Capital IQ were expecting non-GAAP EPS of $0.15.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: AMED , SCLN

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by